These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12667895)

  • 61. Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord.
    Bradaïa A; Schlichter R; Trouslard J
    J Physiol; 2004 Aug; 559(Pt 1):169-86. PubMed ID: 15235081
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus.
    Balázsa T; Bíró J; Gullai N; Ledent C; Sperlágh B
    Neurochem Int; 2008 Jan; 52(1-2):95-102. PubMed ID: 17719142
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.
    Chaki S; Shimazaki T; Karasawa J; Aoki T; Kaku A; Iijima M; Kambe D; Yamamoto S; Kawakita Y; Shibata T; Abe K; Okubo T; Sekiguchi Y; Okuyama S
    Psychopharmacology (Berl); 2015 Aug; 232(15):2849-61. PubMed ID: 25869273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sarcosine preconditioning induces ischemic tolerance against global cerebral ischemia.
    Pinto MC; Simão F; da Costa FL; Rosa DV; de Paiva MJ; Resende RR; Romano-Silva MA; Gomez MV; Gomez RS
    Neuroscience; 2014 Jun; 271():160-9. PubMed ID: 24797328
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glycine transporter-1 inhibition by NFPS promotes neuroprotection against striatal damage models.
    Izidoro Ribeiro R; Almeida Carvalho G; Almeida Chiareli R; Vieira de Assis Lima I; Quaglio Bellozi PM; Oliveira-Lima OC; Oliveira Giacomelli Á; Birbrair A; Santiago Gomez R; Pinheiro de Oliveira AC; Ulrich H; Cunha Xavier Pinto M
    Neurosci Lett; 2024 Mar; 826():137715. PubMed ID: 38460902
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.
    Kalinichev M; Starr KR; Teague S; Bradford AM; Porter RA; Herdon HJ
    Brain Res; 2010 May; 1331():105-13. PubMed ID: 20303337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel physiological mechanism of glycine-induced immunomodulation: Na+-coupled amino acid transporter currents in cultured brain macrophages.
    Schilling T; Eder C
    J Physiol; 2004 Aug; 559(Pt 1):35-40. PubMed ID: 15243140
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
    Tsai G; Lane HY; Yang P; Chong MY; Lange N
    Biol Psychiatry; 2004 Mar; 55(5):452-6. PubMed ID: 15023571
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1.
    Igartua I; Solís JM; Bustamante J
    Neuropharmacology; 2007 Jun; 52(8):1586-95. PubMed ID: 17462677
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of typical and atypical antipsychotics on human glycine transporters.
    Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C
    Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition.
    Gomeza J; Hülsmann S; Ohno K; Eulenburg V; Szöke K; Richter D; Betz H
    Neuron; 2003 Nov; 40(4):785-96. PubMed ID: 14622582
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a scintillation proximity assay for analysis of Na+/Cl- -dependent neurotransmitter transporter activity.
    Williams JB; Mallorga PJ; Lemaire W; Williams DL; Na S; Patel S; Conn PJ; Pettibone DJ; Austin C; Sur C
    Anal Biochem; 2003 Oct; 321(1):31-7. PubMed ID: 12963052
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Functional expression of the glycine transporter 1 on bullfrog retinal cones.
    Zhang XJ; Ge LH; Liu J; Yang XL
    Neuroreport; 2008 Nov; 19(17):1667-71. PubMed ID: 18841092
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
    McCreary AC; Glennon JC; Ashby CR; Meltzer HY; Li Z; Reinders JH; Hesselink MB; Long SK; Herremans AH; van Stuivenberg H; Feenstra RW; Kruse CG
    Neuropsychopharmacology; 2007 Jan; 32(1):78-94. PubMed ID: 16710314
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glycinergic nerve endings in hippocampus and spinal cord release glycine by different mechanisms in response to identical depolarizing stimuli.
    Luccini E; Romei C; Raiteri L
    J Neurochem; 2008 Jun; 105(6):2179-89. PubMed ID: 18298662
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacological properties of glycine uptake in the developing rat retina.
    Salceda R
    Neurochem Int; 2006 Sep; 49(4):342-6. PubMed ID: 16621161
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors.
    Lindsley CW; Wolkenberg SE; Kinney GG
    Curr Top Med Chem; 2006; 6(17):1883-96. PubMed ID: 17017963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and characterization of [¹²⁵I]2-iodo N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide as novel imaging probe for glycine transporter 1.
    Fuchigami T; Haratake M; Magata Y; Haradahira T; Nakayama M
    Bioorg Med Chem; 2011 Nov; 19(21):6245-53. PubMed ID: 21975065
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glycine transporter type-1 and its inhibitors.
    Harsing LG; Juranyi Z; Gacsalyi I; Tapolcsanyi P; Czompa A; Matyus P
    Curr Med Chem; 2006; 13(9):1017-44. PubMed ID: 16611082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.